Platelet rich plasma (PRP) is an autologous biological product harvested by consecutive centrifugations of whole blood and separation of plasma in a stepwise protocol. PRP has been successfully used to stimulate healing in orthopedic and dermatological conditions, both in humans and animals. The principle is the fact that α- granules inside platelets contain a high concentration of growth factors, that once released can interfere with cellular communication and speed up healing. Standardization of PRP requires establishing a gold standard for the preparation and evaluation of the product, especially considering that platelet concentration and, therefore, growth factor concentration, might vary due to a number of variables. Factors such as a...
There has been recent interest regarding the role of autologous platelet-rich plasma (PRP) on soft a...
This paper reviews available reports on the advantages and possibilities of clinical use of platelet...
Graduation date: 2015Access restricted to the OSU Community, at author's request, from July 11, 2014...
Platelet-rich plasma (PRP) commonly refers to blood products which contain a higher platelet (PLT) c...
Abstract Background There is no information on the effects of the breed, gender and age on the cellu...
Platelet-rich plasma (PRP) is an autogenous product obtained from whole blood, through one or two ce...
REASONS FOR PERFORMING STUDY: Autologous platelet concentrates (APCs) are being used increasingly in...
Due to its easy preparation and that it is well tolerated, the use of autologous platelet-rich plasm...
There is a lack of information about the methods used for bovine platelet-rich plasma (PRP)/platelet...
Abstract Platelet rich plasma (PRP) is popularly used in the horse industry to enhance regeneration ...
Background Platelet-rich plasma (PRP) is a product derived from whole blood (WB), characterized by p...
Biotechnology as the platelet-rich plasma (PRP) have been widely used in tissue repair, aiming to ac...
Platelet-rich plasma (PRP) is a nontransfusional hemocomponent, considered as a powerful concentrate...
Platelet-rich plasma (PRP) can be widely used in veterinary medicine in different areas. Studies usi...
The use of platelet rich plasma (PRP) in sports medicine has increased dramatically recently but the...
There has been recent interest regarding the role of autologous platelet-rich plasma (PRP) on soft a...
This paper reviews available reports on the advantages and possibilities of clinical use of platelet...
Graduation date: 2015Access restricted to the OSU Community, at author's request, from July 11, 2014...
Platelet-rich plasma (PRP) commonly refers to blood products which contain a higher platelet (PLT) c...
Abstract Background There is no information on the effects of the breed, gender and age on the cellu...
Platelet-rich plasma (PRP) is an autogenous product obtained from whole blood, through one or two ce...
REASONS FOR PERFORMING STUDY: Autologous platelet concentrates (APCs) are being used increasingly in...
Due to its easy preparation and that it is well tolerated, the use of autologous platelet-rich plasm...
There is a lack of information about the methods used for bovine platelet-rich plasma (PRP)/platelet...
Abstract Platelet rich plasma (PRP) is popularly used in the horse industry to enhance regeneration ...
Background Platelet-rich plasma (PRP) is a product derived from whole blood (WB), characterized by p...
Biotechnology as the platelet-rich plasma (PRP) have been widely used in tissue repair, aiming to ac...
Platelet-rich plasma (PRP) is a nontransfusional hemocomponent, considered as a powerful concentrate...
Platelet-rich plasma (PRP) can be widely used in veterinary medicine in different areas. Studies usi...
The use of platelet rich plasma (PRP) in sports medicine has increased dramatically recently but the...
There has been recent interest regarding the role of autologous platelet-rich plasma (PRP) on soft a...
This paper reviews available reports on the advantages and possibilities of clinical use of platelet...
Graduation date: 2015Access restricted to the OSU Community, at author's request, from July 11, 2014...